Abstract:Abstract Background Research on smoking as a risk factor for death due to COVID-19 remains inconclusive, with different studies demonstrating either an increased or decreased risk of COVID-19 death among smokers. To investigate this controversy, this study uses data from the Netherlands to assess the relationship between smoking and death due to COVID-19. Methods In this population-based quasi-cohort study, we linked pseudonymized individual data on smoking status from the 2016 and 2020 ‘Health Monitor Adults and Elderly’ in the Netherlands (n = 914 494) to data from the cause-of-death registry (n = 2962). Death due to COVID-19 in 2020 or 2021 was taken as the main outcome. Poisson regression modelling was used to calculate relative risks (RRs) and 95% CIs of death due to COVID-19 for current and former smokers compared with never smokers while adjusting for relevant confounders (age, sex, educational level, body mass index and perceived health). Results Former smokers had a higher risk of death due to COVID-19 compared with never smokers across unadjusted (RR, 2.22; 95% CI, 2.04–2.42), age–sex-adjusted (RR, 1.38; 95% CI, 1.22–1.55) and fully adjusted (RR, 1.30; 95% CI, 1.16–1.45) models. Current smokers had a slightly higher risk of death due to COVID-19 compared with never smokers after adjusting for age and sex (RR, 1.21; 95% CI, 1.00–1.48) and after full adjustment (RR, 1.08; 95% CI, 0.90–1.29), although the results were statistically non-significant. Conclusions People with a history of smoking appear to have a higher risk of death due to COVID-19. Further research is needed to investigate which underlying mechanisms may explain this.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the controversy over smoking as a risk factor for COVID - 19 death. Specifically, different studies have different conclusions regarding the risk of death from COVID - 19 among smokers (including current and former smokers). Some studies indicate an increased risk for smokers, while other studies show a decreased risk or no significant difference. To clarify this controversy, this study used data from the Netherlands to evaluate the relationship between smoking status and death from COVID - 19. ### Research Background As of January 2023, COVID - 19 has caused more than 6.6 million deaths worldwide. Some risk factors for COVID - 19 - related deaths have been identified in the literature, including older age, male gender, and having chronic diseases. Although smoking is also considered to be related to COVID - 19 - related deaths, research findings on this risk factor remain inconsistent. ### Research Methods - **Research Design**: This is a population - based quasi - cohort study. The researchers linked pseudo - anonymized individual data from the "Health Monitoring of Adults and the Elderly" in 2016 and 2020 with the Dutch cause - of - death registration data. - **Sample**: The study included 914,494 participants, among whom 2,962 died from COVID - 19 in 2020 or 2021. - **Main Outcome Variable**: Death from COVID - 19 in 2020 or 2021, determined according to the International Classification of Diseases, 10th Revision (ICD - 10) codes U07.1 ("Confirmed COVID - 19 virus") or U07.2 ("Unconfirmed COVID - 19 virus"). - **Independent Variable**: Smoking status was classified as never smoked, former smoker, and current smoker. - **Covariates**: These include age, gender, education level, body mass index (BMI), and self - rated health status. ### Main Findings - **Never Smokers vs. Former Smokers**: After adjusting for relevant confounding factors, the risk of death from COVID - 19 among former smokers was significantly higher than that among never smokers (relative risk RR = 1.30, 95% CI 1.16 - 1.45). - **Never Smokers vs. Current Smokers**: The risk of death from COVID - 19 among current smokers was slightly higher than that among never smokers, but not statistically significant (RR = 1.08, 95% CI 0.90 - 1.29). ### Conclusion This study found that people with a smoking history had a higher risk of death from COVID - 19 in 2020 and 2021. However, compared with never smokers, current smokers did not have a significantly increased risk of death. Future research is needed to confirm this unexpected finding and explore possible mechanisms.

Risk of death due to COVID-19 among current and former smokers in the Netherlands: a population-based quasi-cohort study

Correction To: Low-intensity Cigarette Smoking and Mortality Risks: a Pooled Analysis of Prospective Cohort Studies in Japan.

Smoking and Risk of Negative Outcomes among COVID-19 Patients: A Systematic Review and Meta-Analysis

Protecting effects of smoking against COVID-19: a community-based retrospective cohort study in middle- and older-aged adults

Attitudes Towards Smoking and COVID-19, and Changes in Smoking Behaviors Before and after the Outbreak of COVID-19: A Nationwide Cross-Sectional Survey Study in China

Association of Smoking Status with Outcomes in Hospitalised Patients with COVID-19.

Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study

Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium

A Descriptive Review of Epidemiology of COVID-19 in Smokers

The association between smoking and long-term outcomes after non–ST-segment elevation myocardial infarction in older patients

Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients

Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis

Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth

Association Between Initiation, Intensity, and Cessation of Smoking and Mortality Risk in Patients With Cardiovascular Disease: A Cohort Study

Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States

Smoking and risk for morbidity and mortality in patients who undergoes coronary artery bypass grafting

Prevalence, mortality and risk factors for self-reported COPD among smokers and never smokers, NHANES 1999-2018

The Association of Tobacco Smoking, Second-hand Smoke, and Novel Tobacco Products With COVID-19 Severity and Mortality in Italy: Results From the COSMO-IT Study

COVID-19 Outcome and Tobacco Product Use: Case-Control and Retrospective Cohort Studies Using Nationwide Samples

Smoking Status and Premature Death Among Japanese Rural Community-Dwelling Persons

Smoking Behavior and Prognosis After Colorectal Cancer Diagnosis: A Pooled Analysis of 11 Studies